Study to Evaluate Safety and Immunogenicity of Sub-unit Adjuvanted Influenza Vaccine Administered to Elderly Subjects, Formulation 2011-2012
NCT01344057
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
63
Enrollment
INDUSTRY
Sponsor class
Conditions
Seasonal Influenza
Interventions
BIOLOGICAL:
Seasonal Influenza Vaccine
Sponsor
Novartis Vaccines